Matador Resources Co. MTDR 深 沪
已收盘 10-10 16:00:00 美东时间
42.15
-2.500
-5.60%
华盛通- 最 高44.41
- 今 开43.78
- 成交量 170.82万股
- 最 低 42.12
- 昨 收 44.65
- 总市值 52.69亿
- 52周最高 63.1075
- 市盈率 静 5.91
- 换手率 1.37%
- 52周最低 34.565
- 委 比 -17.98%
- 总股本 1.25亿
- 历史最高 71.2425
- 量 比 0.93
- 振 幅 5.13%
- 历史最低 -1.7525
- 每 手 1
- 风险率 5.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 最高186美元！戴尔科技或多家机构上调目标价； 高盛上调超微公司目标价至210美元
今日重点评级关注：富国银行：维持Kyverna Therapeutics"超配"评级，目标价从24美元升至27美元；Chardan Capital：维持Oculis Holding"买入"评级，目标价从33美元升至51美元
10-09 10:51
Forecasting The Future: 9 Analyst Projections For Matador Resources
Matador Resources (NYSE:MTDR) underwent analysis by 9 analysts in the last quar...
10-09 05:00
Shares of energy and oil related stocks are trading lower due to a weaker outlook for oil prices amid expectations of oversupply.
Shares of energy and oil related stocks are trading lower due to a weaker outlo...
10-08 01:39
Matador Resources Promotes Robert Macalik to CFO Role
An update from Matador Resources ( ($MTDR) ) is now available. Matador Resource...
09-30 18:58
Shares of energy stocks are trading lower amid weakness in oil as investors expect OPEC+ to increase oil output ahead of Sunday's meeting.
Shares of energy stocks are trading lower amid weakness in oil as investors exp...
09-30 02:58
美股大行评级 | 潜在涨幅432.99%！维持"投机性买入"评级，Unicycive Therapeutics获机构升目标价至21美元
今日重点评级关注：Benchmark：维持Unicycive Therapeutics"投机性买入"评级，目标价从3美元升至21美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从17美元升至25美元
09-16 09:48
Mizuho Maintains Outperform on Matador Resources, Lowers Price Target to $69
Mizuho analyst William Janela maintains Matador Resources (NYSE:MTDR) with a Outperform and lowers the price target from $73 to $69.
09-16 00:16
Keybanc Maintains Overweight on Matador Resources, Lowers Price Target to $61
Keybanc analyst Tim Rezvan maintains Matador Resources (NYSE:MTDR) with a Overweight and lowers the price target from $62 to $61.
09-03 21:09
William Blair Initiates Coverage On Matador Resources with Outperform Rating
William Blair analyst Neal Dingmann initiates coverage on Matador Resources (NYSE:MTDR) with a Outperform rating.
08-25 20:00
美股大行评级 | 潜在涨幅166.67%！美银证券上调Rocket Pharmaceuticals目标价至10美元，评级升至"买入"
今日重点评级关注：美银证券：上调Rocket Pharmaceuticals评级至"买入"，目标价从4美元升至10美元；花旗：维持小鹏汽车"买入"评级，目标价从29美元升至29.4美元
08-21 19:00
